Vitkovice Hospital
14
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
44%
4 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Small Bowel Diversion
Role: collaborator
Neuroimaging in Acute Stroke
Role: collaborator
Use of Mucolytic Solution Before Upper Endoscopy
Role: lead
Colorectal Cancer: Screening vs. Non-Screening
Role: collaborator
Mucolytic Solution Before Upper Endoscopy
Role: lead
Carbon Dioxide Insufflation Colonoscopy in IBD Patients
Role: lead
EUS-FNA Versus KHB in Diagnostics of Upper Gastrointestinal Submucosal Tumors
Role: lead
Cap-assisted Water Immersion Versus Water Immersion Colonoscopy
Role: lead
Endoscopic Treatment for Local Residual Neoplasia
Role: lead
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
Role: lead
Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants
Role: collaborator
Warm Water Versus Room Temperature Water Immersion Colonoscopy
Role: lead
Risk Factors for Residual Neoplasia After Endoscopic Mucosal Resection
Role: lead
Combination of Water Immersion and Carbon Dioxide Insufflation for Minimal Sedation Colonoscopy
Role: lead
All 14 trials loaded